Resources
Breakfast Presentation
23rd November, 2017
Brenda Dooley, Managing Director at AXIS Consulting
Benda gave an overview of the HTA process in Ireland, highlighted common pitfalls and gave her top tips for success in this highly complex process.
7th September, 2017
Professor Michael Barry, Clinical Director with the National Centre for Pharmaeconomics (NCPE)
Prof Michael Barry gave an in-depth review of the Reimbursement process, the growth of Rare Disease Drugs and as a consequence, the rise in complex HTA submissions – 49 submissions so far in 2017, with 39 of these being Cancer/Rare Disease submissions.
David Magee, Head of Memberships with the Irish Management Institute (IMI)
Following on from the launch of the PMI’s partnership with the IMI on September 1st, David gave an overview of the benefits now available to PMI members, and how best to avail of them.
22nd June, 2017
Orlaith Brennan, Director of Commercial Affairs with Irish Pharmaceutical Healthcare Association (IPHA)
Orlaith spoke to our members about the Drugs Agreement and how the process has evolved in it’s first year. She outlined some areas where roadblocks are occurring and what IPHA are doing to try to alleviate these.
Simon Nugent, CEO with the Private Hospitals Association
Following on from the launch of the PMI’s partnership with the IMI on September 1st, David gave an overview of the benefits now available to PMI members, and how best to avail of them.
9th February, 2017.
Tony O’Brien, Director General with the HSE
Tony spoke to our members on February 9th, outlining the challenges and difficulties currently facing the HSE – and how to overcome them.